<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Wenxin Keli is the first state‑sanctioned traditional Chinese medicine (TCM)-based antiarrhythmic drug </plain></SENT>
<SENT sid="1" pm="."><plain>The present study aimed to examine whether long‑term treatment with Wenxin Keli reduces <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>‑induced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in rats in vivo, and if so, which mechanisms are involved </plain></SENT>
<SENT sid="2" pm="."><plain>Male rats were treated with either saline (control group) or Wenxin Keli for 3 weeks and were subjected to <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> for 30 min with assessment of the resulting <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The L‑type calcium current (ICa,L) and transient outward <z:chebi fb="120" ids="26216">potassium</z:chebi> current (Ito) were measured by the patch clamp technique in <z:mpath ids='MPATH_458'>normal</z:mpath> rat cardiac ventricular myocytes </plain></SENT>
<SENT sid="4" pm="."><plain>During the 30‑min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, Wenxin Keli significantly reduced the incidence of <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) (P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The number of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT)+<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> episodes and the severity of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> were significantly reduced by Wenxin Keli administration compared to the control group (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, Wenxin Keli inhibited ICa,L and Ito in a concentration‑dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that long‑term treatment with Wenxin Keli may attenuate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>‑induced <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in rats and that ICa,L and Ito may be involved in this attenuation </plain></SENT>
</text></document>